MannKind to Acquire scPharmaceuticals, Expanding into Cardiorenal Medicine
MannKind’s acquisition of scPharmaceuticals is expected to be completed in the fourth quarter of 2025.
With Chronic Heart Failure (CHF) | 25/08/2025 | By Dineshwori | 132
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy